{"title":"Clinical Features and Risk Factors for Early Bone Destruction in Enthesitis-Related Arthritis: A Cohort Study","authors":"Jianqiang Wu, Xiaolong Qiu, Minfei Hu, Yandie Li, Xinghui Yang, Yingzi Hu, Meiping Lu","doi":"10.1111/1756-185X.70176","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Objectives</h3>\n \n <p>To explore the clinical characteristics and identify risk factors for early bone destruction in children with enthesitis-related arthritis (ERA).</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Clinical characteristics were retrospectively analyzed in 85 newly diagnosed cases with ERA at our hospital from January 2019 to December 2021. Logistic regression analyses were performed to identify risk factors for early bone destruction.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>In this cohort of 85 ERA patients, early bone destruction was identified in 24.7% (21/85) of cases (ERA-BD group), predominantly affecting the sacroiliac joints (66.7%), knee (14.3%), hip (14.3%), and interphalangeal joints (4.8%). The ERA-BD group exhibited significantly higher rates of polyarticular involvement (≥ 5 joints) compared to the ERA-nBD group (76.2% vs. 12.5%, <i>p</i> < 0.001), with a notably higher incidence of knee joint involvement (66.7% vs. 40.6%, <i>p</i> < 0.05) and sacroiliitis (85.7% vs. 50.0%, <i>p</i> < 0.05). Additionally, the ERA-BD group had a longer disease duration (8.0 vs. 3.5 months, <i>p</i> = 0.009) and elevated C-reactive protein levels (median: 12.3 vs. 4.4 mg/L, <i>p</i> = 0.04). However, no significant differences were observed in ESR or IL-6 levels between the two groups. Multivariate analysis confirmed that polyarticular involvement (OR = 21.39, 95% CI 5.12–89.30) and longer disease duration (OR = 4.06, 95% CI 1.33–12.39) were independent predictors of early bone destruction.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Our study identifies polyarticular involvement (≥ 5 joints) and longer disease duration as key independent predictors of early bone destruction in ERA, highlighting the need for a shift from joint-specific to systemic risk stratification.</p>\n </section>\n </div>","PeriodicalId":14330,"journal":{"name":"International Journal of Rheumatic Diseases","volume":"28 3","pages":""},"PeriodicalIF":2.0000,"publicationDate":"2025-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Rheumatic Diseases","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/1756-185X.70176","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives
To explore the clinical characteristics and identify risk factors for early bone destruction in children with enthesitis-related arthritis (ERA).
Methods
Clinical characteristics were retrospectively analyzed in 85 newly diagnosed cases with ERA at our hospital from January 2019 to December 2021. Logistic regression analyses were performed to identify risk factors for early bone destruction.
Results
In this cohort of 85 ERA patients, early bone destruction was identified in 24.7% (21/85) of cases (ERA-BD group), predominantly affecting the sacroiliac joints (66.7%), knee (14.3%), hip (14.3%), and interphalangeal joints (4.8%). The ERA-BD group exhibited significantly higher rates of polyarticular involvement (≥ 5 joints) compared to the ERA-nBD group (76.2% vs. 12.5%, p < 0.001), with a notably higher incidence of knee joint involvement (66.7% vs. 40.6%, p < 0.05) and sacroiliitis (85.7% vs. 50.0%, p < 0.05). Additionally, the ERA-BD group had a longer disease duration (8.0 vs. 3.5 months, p = 0.009) and elevated C-reactive protein levels (median: 12.3 vs. 4.4 mg/L, p = 0.04). However, no significant differences were observed in ESR or IL-6 levels between the two groups. Multivariate analysis confirmed that polyarticular involvement (OR = 21.39, 95% CI 5.12–89.30) and longer disease duration (OR = 4.06, 95% CI 1.33–12.39) were independent predictors of early bone destruction.
Conclusions
Our study identifies polyarticular involvement (≥ 5 joints) and longer disease duration as key independent predictors of early bone destruction in ERA, highlighting the need for a shift from joint-specific to systemic risk stratification.
目的探讨过敏性关节炎(ERA)患儿早期骨破坏的临床特点及危险因素。方法回顾性分析2019年1月至2021年12月我院85例新诊断ERA的临床特点。进行逻辑回归分析以确定早期骨破坏的危险因素。结果在85例ERA患者中,有24.7%(21/85)的病例(ERA- bd组)发现早期骨破坏,主要影响骶髂关节(66.7%)、膝关节(14.3%)、髋关节(14.3%)和指间关节(4.8%)。ERA-BD组多关节受累(≥5个关节)的发生率明显高于ERA-nBD组(76.2% vs. 12.5%, p < 0.001),膝关节受累(66.7% vs. 40.6%, p < 0.05)和骶髂炎(85.7% vs. 50.0%, p < 0.05)的发生率显著高于ERA-nBD组(p < 0.05)。此外,ERA-BD组病程更长(8.0个月vs 3.5个月,p = 0.009), c反应蛋白水平升高(中位数:12.3 vs 4.4 mg/L, p = 0.04)。然而,两组之间ESR或IL-6水平无显著差异。多因素分析证实,多关节受累(OR = 21.39, 95% CI 5.12-89.30)和较长的病程(OR = 4.06, 95% CI 1.33-12.39)是早期骨破坏的独立预测因素。我们的研究确定了多关节受累(≥5个关节)和更长的疾病持续时间是ERA早期骨破坏的关键独立预测因素,强调了从关节特异性转向系统性风险分层的必要性。
期刊介绍:
The International Journal of Rheumatic Diseases (formerly APLAR Journal of Rheumatology) is the official journal of the Asia Pacific League of Associations for Rheumatology. The Journal accepts original articles on clinical or experimental research pertinent to the rheumatic diseases, work on connective tissue diseases and other immune and allergic disorders. The acceptance criteria for all papers are the quality and originality of the research and its significance to our readership. Except where otherwise stated, manuscripts are peer reviewed by two anonymous reviewers and the Editor.